NFL Group, Company Teaming Up for Brain Drug Test
A potential treatment for traumatic brain injuries may be tested in retired professional football players, who are the focus of concern over blows to the head.
Neuralstem, Inc., of Rockville, Md., said Wednesday it is working with the National Football League Alumni Association to study the feasibility of such a test, which would need government approval. It would involve a drug that’s now in an early human trial for treating depression. In animal studies, the drug appeared to stimulate creation of brain cells.
- Will California’s New Smoke Claims Law Create a Recovery Bottleneck?
- Agentic Intelligence for Claims Dominates New Tech Launches
- UIM Minimum Limits. A Coverage That May Not Pay?
- Warren, Hawley Press Insurers Over Closed, Unpaid Claims
- The Great Hemp Reset: How the Federal Ban on Intoxicating Hemp Products Will Reshape Risk and Coverage
- The Nation’s Insurance Laboratory: What Liability Trends in California Mean for the Rest of the Country
- Credit Acceptance Reaches $710M Predatory Auto Lending Settlement With Most States
- Severe Convective Storms: Risk, Field Reality and the Path to Resilience